GeneNews to Present at OneMedPlace Financial Forum
TORONTO, CANADA (January 11, 2010):
GeneNews Limited (TSX: GEN), an emerging molecular diagnostics and personalized health management company, today announced that Gailina J. Liew, newly appointed as the company’s President and Chief Operating Officer, will present at the OneMedPlace Financial Forum in San Francisco, California, on Tuesday January 12th, 2010. The presentation will take place at 8:00 a.m. Pacific Time at the Sir Francis Drake Hotel. Held annually in San Francisco, the OneMedPlace Financial Forum was created to feature emerging healthcare and life science companies to foster connections with investors and strategic partners.
About GeneNews
GeneNews is an emerging molecular diagnostics company focused on the application of functional genomics to enable early diagnosis and personalized health management based on disease-specific biomarkers. The Company has a patented core platform technology, the Sentinel Principle®, which has the power to detect and stage virtually any disease or medical condition from a simple blood sample. GeneNews is currently applying the Sentinel Principle® in major areas with unmet clinical needs such as cancer, arthritis, cardiovascular disease and neurological disorders. GeneNews launched its first commercial product, ColonSentry™, a blood-based test to pre-screen and assess an individual's risk for colorectal cancer, in Canada in 2008. The company's first US marketing partner, Enzo Clinical Labs, is expected to launch the ColonSentry™ test in New York and New Jersey in the second half of 2010. For more information on GeneNews and ColonSentry™, visit www.genenews.com or www.ColonSentry.com.
Forward-Looking Statements
This press release contains forward-looking statements, which reflect the Company's current expectations regarding future events. The forward-looking statements involve risks and uncertainties. Actual events could differ materially from those projected herein. Investors should consult the Company's ongoing quarterly filings and annual reports for additional information on risks and uncertainties relating to these forward-looking statements. The reader is cautioned not to rely on these forward-looking statements. The Company disclaims any obligation to update these forward-looking statements.